IDEAYA Biosciences, Inc., a precision medicine oncology company, announced on June 27, 2025, that its Board of Directors' Compensation Committee has granted non-qualified stock options for a total of 95,600 shares to a newly hired employee. These options, issued under the IDEAYA Biosciences, Inc. 2023 Employment Inducement Incentive Award Plan, were given as an inducement for joining the company. The stock options have an exercise price of $22.29 per share, corresponding to the closing price on the Nasdaq Global Select Market on the grant date. With a 10-year term, the options vest over four years, starting with 25% after the first year and the remaining 75% in equal monthly installments over the subsequent three years, contingent on the employee's continued service to IDEAYA.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.